Cancer Therapy: Nanokey Opens Tumors to Attack

Published November 15, 2012

Cancer therapy: Nanokey opens tumors to attack

Filed under: drug treatment news 2012

Treatment with the loaded nanoparticles alone, however, had only a moderate effect on tumor cells, but when they were administered in combination with the DNA-intercalating drug doxorubicin, the impact on tumor cell growth was markedly enhanced …
Read more on Medical Xpress

Auspex Pharmaceuticals Receives U.S. Patent on Novel JAK Inhibitor SD-900

Filed under: drug treatment news 2012

15, 2012 — /PRNewswire/ — Auspex Pharmaceuticals, Inc. today announced that it has been granted U.S. Patent No. 8,299,084 covering the company's novel JAK kinase inhibitor SD-900, a deuterium-substituted … The JAK kinases have emerged as important …
Read more on Sacramento Bee

Clovis tumbles on pancreatic cancer drug failure

Filed under: drug treatment news 2012

NEW YORK (AP) — Shares of Clovis Oncology Inc. plunged Monday after the company said its drug CO-101 failed in a clinical trial as a treatment for pancreatic cancer. THE SPARK: … Clovis said it expects to end 2012 with about $ 140 million in cash …
Read more on Businessweek